Chevron New Com (CVX) Stock Declined While Waters Parkerson & Company Increased by $381,784 Its Position; Teva Pharmaceutical Inds LTD (TEVA) Holder Aimz Investment Advisors Boosted Position

December 18, 2017 - By Adrian Erickson

Aimz Investment Advisors Llc increased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 30.28% based on its latest 2017Q2 regulatory filing with the SEC. Aimz Investment Advisors Llc bought 20,011 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 86,090 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $2.86M, up from 66,079 at the end of the previous reported quarter. Aimz Investment Advisors Llc who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be bullish on the $18.91 billion market cap company. The stock increased 7.57% or $1.31 during the last trading session, reaching $18.61. About 66.14 million shares traded or 157.39% up from the average. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since December 18, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Waters Parkerson & Company increased its stake in Chevron Corp New Com (CVX) by 1.53% based on its latest 2017Q2 regulatory filing with the SEC. Waters Parkerson & Company bought 3,671 shares as the company’s stock declined 3.45% while stock markets rallied. The institutional investor held 243,594 shares of the integrated oil company at the end of 2017Q2, valued at $25.41M, up from 239,923 at the end of the previous reported quarter. Waters Parkerson & Company who had been investing in Chevron Corp New Com for a number of months, seems to be bullish on the $227.41B market cap company. The stock increased 0.17% or $0.2 during the last trading session, reaching $119.73. About 11.23M shares traded or 123.31% up from the average. Chevron Corporation (NYSE:CVX) has risen 6.68% since December 18, 2016 and is uptrending. It has underperformed by 10.02% the S&P500.

Among 34 analysts covering Chevron Corporation (NYSE:CVX), 22 have Buy rating, 1 Sell and 11 Hold. Therefore 65% are positive. Chevron Corporation had 94 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, April 12 by Jefferies. The firm has “Equal-Weight” rating given on Tuesday, October 10 by Barclays Capital. On Tuesday, September 19 the stock rating was maintained by RBC Capital Markets with “Sell”. Raymond James downgraded the stock to “Market Perform” rating in Tuesday, March 22 report. The rating was maintained by Piper Jaffray on Thursday, September 28 with “Buy”. The firm earned “Hold” rating on Tuesday, January 10 by HSBC. The stock of Chevron Corporation (NYSE:CVX) has “Buy” rating given on Thursday, August 24 by Piper Jaffray. Macquarie Research upgraded the shares of CVX in report on Tuesday, October 17 to “Buy” rating. The stock has “Hold” rating by RBC Capital Markets on Friday, March 24. On Wednesday, March 9 the stock rating was maintained by RBC Capital Markets with “Sector Perform”.

Since August 1, 2017, it had 0 insider purchases, and 4 sales for $11.07 million activity. $3.06M worth of Chevron Corporation (NYSE:CVX) was sold by Pate R. Hewitt on Monday, October 16. 31,000 shares valued at $3.43 million were sold by JOHNSON JAMES WILLIAM on Tuesday, August 1. 2,312 shares were sold by Deily Linnet F, worth $248,274 on Wednesday, August 16.

Investors sentiment increased to 1.03 in 2017 Q2. Its up 0.06, from 0.97 in 2017Q1. It is positive, as 65 investors sold CVX shares while 653 reduced holdings. 92 funds opened positions while 651 raised stakes. 1.16 billion shares or 0.51% more from 1.16 billion shares in 2017Q1 were reported. Optimum Inv Advsrs has 0.64% invested in Chevron Corporation (NYSE:CVX) for 17,610 shares. Liberty Mutual Group Asset Mngmt has 121,024 shares. Montgomery Inv Management reported 3.62% of its portfolio in Chevron Corporation (NYSE:CVX). Paradigm Fin Advsr has 8,837 shares. Rhumbline Advisers reported 3.40M shares or 0.81% of all its holdings. Mackenzie Fincl Corp owns 8,543 shares. 33,986 are owned by Ca. Sheets Smith Wealth Mngmt accumulated 0.49% or 17,721 shares. Bluemountain Capital Ltd Limited Liability Company stated it has 0.01% in Chevron Corporation (NYSE:CVX). Joel Isaacson Lc reported 0.21% stake. Braun Stacey Assoc Inc invested 1.12% of its portfolio in Chevron Corporation (NYSE:CVX). Fred Alger Mngmt Inc reported 0% stake. Delta Asset Mngmt Ltd Company Tn owns 0.13% invested in Chevron Corporation (NYSE:CVX) for 8,302 shares. Adell Harriman Carpenter reported 0% of its portfolio in Chevron Corporation (NYSE:CVX). Everett Harris Communications Ca reported 296,172 shares.

Among 32 analysts covering Teva Pharma (NYSE:TEVA), 8 have Buy rating, 5 Sell and 19 Hold. Therefore 25% are positive. Teva Pharma had 120 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Tuesday, July 25 with “Hold”. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Underperform” rating by JMP Securities on Wednesday, September 6. RBC Capital Markets maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Thursday, October 19. RBC Capital Markets has “Sell” rating and $15.0 target. Piper Jaffray maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Friday, October 6. Piper Jaffray has “Hold” rating and $23.0 target. The rating was maintained by Jefferies with “Hold” on Thursday, June 22. Mizuho maintained it with “Neutral” rating and $40 target in Wednesday, November 16 report. The stock has “Buy” rating by Deutsche Bank on Tuesday, July 28. On Monday, August 7 the stock rating was downgraded by Morgan Stanley to “Underweight”. On Tuesday, January 31 the stock rating was upgraded by Bank of America to “Buy”. The rating was maintained by Mizuho on Wednesday, August 2 with “Hold”.